LakeShore Biopharma Co., Ltd Cash Flow Reinvestment Rate

Latest as of June 2021: 0.00x

LakeShore Biopharma Co., Ltd cash flow reinvestment rate. LakeShore Biopharma Co., Ltd (LSB) has a Cash Flow Reinvestment Rate of 0.00x as of June 2021, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $2.34 Million. Explore cash flow to debt ratio of LakeShore Biopharma Co., Ltd to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

0.00x
(Capex + Investments) / Operating CF

Total Reinvested

$0.00
Capex + Investments

Operating Cash Flow

$2.34 Million
USD

Capital Expenditures

$0.00
USD

LakeShore Biopharma Co., Ltd Cash Flow Reinvestment Rate by Year (None–None)

LakeShore Biopharma Co., Ltd cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for LakeShore Biopharma Co., Ltd. For the full cash flow conversion analysis, see cash efficiency ratio of LakeShore Biopharma Co., Ltd.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow